1. Patel E. U. Patel E. U., Thio C. L., et al. Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016. Clin. Infec. Dis. 2019;69:709-712
2. Do A., Reo N. S. Chronic viral hepatitis: current management and future directions. Gerrat Comm. 2020; 4:329-341
3. Vincent T. L., SavianoA., Schuster C., et al. Targeting the Host for New Therapeutic Perspectives in Hepatitis D. J. Clin. Med. 2020;9:1
4. Tobokalova S. T. Acute hepatitis B and D in children with concomitant pathology. diss. Dr. medical Sciences: 14.00.09. Moscow, 2004. (in Russ.) @@Tobokalova S. T. Ostrye gepatity V i D u detei s soputstvuyushchei patologiei: avtoref. dis. … d-ra med. nauk: 14.00.09 / - Moskva, 2004
5. Suranbaeva G. S. Chronic viral hepatitis B, C, D in the Kyrgyz Republic (clinical and therapeutic aspects). diss. Dr. medical Sciences: 14.01.09. Bishkek. 2012. 212 p. (in Russ.) @@Suranbaeva G. S. Khronicheskie virusnye gepatity B, C, D v Kyrgyzskoi Respublike (klinicheskie i terapevticheskie aspekty): dis. d-ra. med. nauk: 14.01.09 / - Bishkek, 2012. - 212 s